Timely articles and studies, news, quizzes, and free downloads
New! Risk of Heart Disease in Breast Cancer Patients Predicted From Routine Scans
Automated analysis of breast cancer patients' routine scans can predict which women have a greater than one in four risk of going on to develop cardiovascular disease, according to research presented at the 12th European Breast Cancer Conference. Women who have been treated for breast cancer may have a higher risk of developing cardiovascular disease and in some groups the risk of dying from cardiovascular disease is higher than the risk of dying from breast cancer.
Genomic Profiling Analysis in Breast Cancer Testing
Precision oncological medicine proved beneficial in research at the 2020 ASCO Annual Meeting, presented by first author Adam Brufsky, MD, PhD (Abstract 3570). Conclusions from the study highlighted the need for improved biomarkers to more precisely identify patients who could benefit from HER2-directed agents.
An excerpt from Cancer Screening Decisions, a hands-on tool for clinicians to use with patients as they weigh the personal advantages and disadvantages of cancer screenings. Taking a uniquely visual approach, every page offers clear, colorful graphics to walk you and your patients through every step of the decision-making process for breast cancer.
HDAC6 Controls Tumor Growth, Metastasis in Triple-Negative Breast Cancer
Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according investigators at the George Washington University (GW) Cancer Center (Cancer Research 2020; doi: 10.1158/0008-5472.CAN-19-3738).